title: [Risk of thromboembolism in atrial fibrillation].
abstract: Atrial fibrillation is considered as one of the cardiovascular pandemics of our days due to its increasing prevalence and the significant burden on healthcare systems. Management, especially prevention of thromboembolism associated with the arrhythmia is still a challenge even with recently available treatment options. Herein, the author reviews the possibilities of risk stratification and stroke prevention, which are important to all medical professionals who potentially encounter patients with this arrhythmia. Orv. Hetil., 2016, 157(38), 1511-1515.
authors.affiliation: Kardiológiai és Szívsebészeti Klinika, Debreceni Egyetem, Klinikai Központ Debrecen, Móricz Zsigmond krt. 22., 4032.
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Csanádi
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000517:prevention & control; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants
keywords: anticoagulant therapy; antikoaguláns kezelés; atrial fibrillation; pitvarfibrilláció; stroke; thromboembolia; thromboembolism